Literature DB >> 34964910

Caudate lobe amebic abscesses: percutaneous image-guided aspiration or drainage.

Tanya Yadav1, Ranjan K Patel1, Akash Bansal1, Navojit Chatterjee1, Yashwant Patidar1, Amar Mukund2.   

Abstract

BACKGROUND: Amebic liver abscess is the most common type of liver abscess on a worldwide basis, with caudate lobe being a relatively uncommon location for its occurrence. Abscess in caudate lobe of liver is often considered a challenging location for image-guided percutaneous drainage due to its difficult-to-access location along with close relationship with major vessels at porta hepatis.
PURPOSE: This study aims to demonstrate safety and efficacy of percutaneous drainage for caudate lobe amebic abscess.
MATERIALS AND METHODS: In this retrospective study, hospital database was electronically searched for patients having caudate lobe amebic abscess that underwent percutaneous catheter drainage/needle aspiration (PCD/PNA) between January 2016 and January 2021. The etiology, risk factors, microbiology, complications, different approaches for PCD/PNA, and their outcome were studied and reported.
RESULTS: Of 30 patients having caudate lobe amebic abscess treated with PCD/PNA, solitary caudate lobe abscess was seen in 29, whereas one patient had more than one abscesses in caudate lobe. Contained and free intraperitoneal rupture of the abscess were seen in 9 (30%) and one patient, respectively. Ten (32%) patients had associated vascular thrombosis, while 2 patients were found to have abscess-biliary communication. Twenty-six (86.7%) patients were treated with PCD, while remaining 4 (13.3%) with PNA. On Univariate analysis, factors such as volume, multilocularity, and contained rupture of the abscess were found to be significantly increasing the duration of percutaneous drainage (PCD), while only multilocularity (p value 0.007) continued to show statistical significance on Multivariate analysis. Venous thrombosis and duration of catheter drainage were the two factors found to have significant influence on the length of hospital stay on Univariate as well as Multivariate analysis (p value 0.05 and 0.001, respectively). The rates of catheter manipulation were also significantly higher in patients with abscess showing complex internal configuration (heteroechoic contents and/or multilocularity). Technical and clinical success rates of 100% and 96.7% were achieved through percutaneous interventions (PCD/PNA), despite the complex location of abscesses and associated complications, with no incidence of vascular injury.
CONCLUSION: Liver abscess in caudate lobe can be accessed by different routes for percutaneous drainage, despite being surrounded by large vessels and its deep location, without major complications. Thus, PCD/PNA may be considered as a first-line therapy for the management of caudate lobe amebic abscesses in adjunct to medical therapy.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Caudate lobe; Liver abscess; Percutaneous intervention; Porta hepatis; Ultrasonography

Mesh:

Year:  2021        PMID: 34964910     DOI: 10.1007/s00261-021-03395-z

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  20 in total

1.  Surgical management of pyogenic liver abscess.

Authors:  A Onder; M Kapan; A Böyük; M Gümüş; G Tekbaş; S Girgin; I H Tacyildiz
Journal:  Eur Rev Med Pharmacol Sci       Date:  2011-10       Impact factor: 3.507

2.  Amebic Liver Abscess.

Authors:  Wolfram Goessling; Raymond T. Chung
Journal:  Curr Treat Options Gastroenterol       Date:  2002-12

3.  A review of amoebic liver abscess for clinicians in a nonendemic setting.

Authors:  Terry Wuerz; Jennifer B Kane; Andrea K Boggild; Sigmund Krajden; Jay S Keystone; Milan Fuksa; Kevin C Kain; Ralph Warren; John Kempston; Joe Anderson
Journal:  Can J Gastroenterol       Date:  2012-10       Impact factor: 3.522

4.  Percutaneous radiofrequency ablation for treatment of hepatocellular carcinoma in the caudate lobe.

Authors:  Kazuya Kariyama; Kazuhiro Nouso; Akiko Wakuta; Masayuki Kishida; Mamoru Nishimura; Nozomu Wada; Toshihiro Higashi
Journal:  AJR Am J Roentgenol       Date:  2011-10       Impact factor: 3.959

Review 5.  The caudate lobe of the liver: implications of embryology and anatomy for surgery.

Authors:  Eddie K Abdalla; Jean-Nicolas Vauthey; Claude Couinaud
Journal:  Surg Oncol Clin N Am       Date:  2002-10       Impact factor: 3.495

6.  Amoebic liver abscess: presentation and complications.

Authors:  Madhumita Mukhopadhyay; Anil Kumar Saha; Amitava Sarkar; Swadhin Mukherjee
Journal:  Indian J Surg       Date:  2010-02-05       Impact factor: 0.656

7.  Management Practices and Predictors of Outcome of Liver Abscess in Adults: A Series of 1630 Patients from a Liver Unit.

Authors:  Ankur Jindal; Apurva Pandey; Manoj K Sharma; Amar Mukund; Rajan Vijayaraghavan; Vinod Arora; Saggere M Shasthry; Ashok Choudhary; Shiv K Sarin
Journal:  J Clin Exp Hepatol       Date:  2020-10-15

8.  Endoscopic ultrasound-guided transgastric drainage of radiologically inaccessible left lobe liver abscess involving segment 4, caudate lobe, and left lateral segments using a modified technique.

Authors:  Sharad Chandra; Urvashi Chandra
Journal:  Endosc Int Open       Date:  2021-01-01

9.  Colonic involvement in amebic liver abscess: does site matter?

Authors:  Amitava Goswami; Sunil Dadhich; Narendra Bhargava
Journal:  Ann Gastroenterol       Date:  2014

10.  The "Vessel through Strait" Sign is a Signature Radiological Sign for the Diagnosis of Left Hepatic Artery Variation.

Authors:  Guanghua Rong; Zhijun Wang; Ximing Wang; Qiang Yu; Lin Zhou; Huaming Wang; Junhua Zhang; Jinghui Dong; Wei Ma; Weimin An; Hui Ren; Zhen Zeng; Yinying Lu; Yongwu Li
Journal:  Sci Rep       Date:  2016-04-04       Impact factor: 4.379

View more
  1 in total

Review 1.  Amebic liver abscess: Clinico-radiological findings and interventional management.

Authors:  Rajeev Nayan Priyadarshi; Ramesh Kumar; Utpal Anand
Journal:  World J Radiol       Date:  2022-08-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.